𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Glial cell line-derived neurotrophic factor (GDNF): a drug candidate for the treatment of Parkinson’s disease

✍ Scribed by R. Grondin; Don M. Gash


Publisher
Springer
Year
1998
Tongue
English
Weight
85 KB
Volume
245
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


In vivo gene delivery of glial cell line
✍ Jeffrey H. Kordower 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 564 KB

Parkinson's disease (PD) is a progressive neurodegenerative disorder that affects approximately 1,000,000 Americans. The cause of the disease remains unknown. The histopathological hallmarks of the disease are dopaminergic striatal insufficiency secondary to a loss of dopaminergic neurons in the sub

Glial cell line-derived neurotrophic fac
✍ Matheson, Christine R. ;Carnahan, Josette ;Urich, Janal L. ;Bocangel, Dora ;Zhan 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 295 KB 👁 2 views

We compared the effects of glial cell 3 did not promote any detectable level of neuronal line-derived neurotrophic factor (GDNF) on dorsal survival despite the fact that they underwent retroroot ganglion (DRG) sensory neurons to that of nerve growth factor (NGF), brain-derived neurotrophic grade tra

Long-term neuroprotection and neuroresto
✍ Elisa Garbayo; Eduardo Ansorena; Jose Luis Lanciego; María Jose Blanco-Prieto; M 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 678 KB

## Abstract ## Background: Glial cell‐derived neurotrophic factor is a survival factor for dopaminergic neurons and a promising candidate for the treatment of Parkinson's disease. However, the delivery issue of the protein to the brain still remains unsolved. Our aim was to investigate the effect